Human Microbiome Market Size, Global Analysis & Forecast 2028

    Human Microbiome Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others) and Application (Therapeutics and Diagnostics) and Geography

    Publication Month: Aug 2021 | Report Code: TIPBT00002233 | No. of Pages: 188 | Category: Biotechnology | Status: Published

    The human microbiome market is expected to reach US$ 2,921.68 million by 2028 from US$ 718.95 million in 2021; it is estimated to grow at a CAGR of 22.2% during 2021–2028.

    The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. The microbes, including bacteria, fungi, and viruses, are the disease-causing agent that accumulate over time, and the habitat in gut transforms their genetic activities and metabolic processes, resulting in an abnormal immune response against the substances and tissues that normally present in the human body. Several microbiome projects have been launched worldwide with the aim to understand the roles played by these symbionts and their impact on the health of human host. The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.

    Lucrative Regions for Human Microbiome Market

    Get more information on this report :



    Market Insights

    Increasing Incidence of Lifestyle Diseases

    In the past few decades, researchers have come up with the clarity on the relation between human microbiome and lifestyle diseases such as cancer, diabetes, obesity, and depression. Changes in lifestyles and societal norms influence the microbiome at each stage of life. Altering the human microbiome can help eliminate such lifestyle diseases. As per World Health Organization, 13% of the world population (adults) was obese in 2016. According to the “The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation,” published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ whose composition and functionality contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), involving the transfer of feces from a healthy donor to the patient, is a potential treatment for obesity.


    Diabetes is one of the global health emergencies of the 21st century. According to the International Diabetes Federation (IDF), the number of people suffering from diabetes in North America was ~46 million in 2017, which is expected to rise to 62 million by 2045, i.e., with the disease prevalence of ~35% during the forecast period. The reduced levels of Firmicutes Clostridia indicate the microbiome of patients with diabetes butyrate-producing bacteria and an increased ratio of Bacteroidetes: Firmicutes. Thus, diabetes can be prevented as well as treated by altering the microbiome by administration of prebiotics, probiotics, and fecal transplantation. Therefore, the increasing incidence of chronic lifestyle diseases is driving the human microbiome market growth.

    Product-Based Insights

    Based on product, the human microbiome market is segmented into foods, medical foods, probiotics, prebiotics, drugs, diagnostic devices, and supplements. The probiotics segment is projected to hold the largest market share in 2021, and the prebiotics segment is anticipated to register the highest CAGR in the market during the forecast period.

    Human Microbiome Market, by Product – 2021 and 2028
    Human Microbiome Market, by Product – 2021 and 2028

    Get more information on this report :



    Report Coverage

    Disease-Based Insights

    The human microbiome market, by disease, is segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders, and other diseases. The market for the human microbiome is emerging owing to rising incidences of lifestyle diseases such as cancer and diabetes. The obesity segment is expected to hold the largest share of the market in 2021, whereas the diabetes segment is estimated to register the highest CAGR during the forecast period.

    Application-Based Insights

    The human microbiome market, by application, is segmented into diagnostics and therapeutics. The therapeutics segment is projected to hold a larger market share in 2021, and it is further estimated to register a higher CAGR during the forecast period.

    Strategic Insights

    Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Companies in the human microbiome market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

    Human Microbiome Market – by Product

    • Probiotics
    • Foods
    • Prebiotics
    • Medical Foods
    • Diagnostic Devices
    • Drugs
    • Supplements

    Human Microbiome Market – by Disease

    • Obesity
    • Diabetes
    • Autoimmune Disorders
    • Cancer
    • Mental Disorders
    • Others

    Human Microbiome Market – by Application

    • Therapeutics
    • Diagnostics

    Human Microbiome Market – by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of Asia Pacific
    • Middle East and Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of Middle East and Africa
    • South and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles


    • Rebiotix Inc.
    • Yakult Honsha Co., Ltd.
    • Synthetic Biologics Inc.
    • DuPont
    • MaaT Pharma
    • Eligo Bioscience
    • Merck & Co. Inc
    • AOBiome LLC
    • Kaleido
    • Seres Therapeutics

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Human Microbiome Market – By Product

    1.3.2 Global Human Microbiome Market – By Disease

    1.3.3 Global Human Microbiome Market – By Application

    1.3.4 Global Human Microbiome Market – By Geography

    2. Global Human Microbiome Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Human Microbiome Market – Market Landscape

    4.1 Overview

    4.1.1 North America – PEST Analysis

    4.1.2 Europe– PEST Analysis

    4.1.3 Asia Pacific– PEST Analysis

    4.1.4 Middle East And Africa– PEST Analysis

    4.1.5 South and Central America – PEST Analysis

    4.2 Expert Opinions

    5. Human Microbiome Market– Key Market Dynamics

    5.1 Key Market Drivers

    5.1.1 Increasing Incidence of Lifestyle Diseases

    5.1.2 Increasing Focus On Human Microbiome Therapies

    5.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing

    5.2 Key Market Restraints

    5.2.1 Strict Government Guidelines

    5.2.2 Lack of Knowledge and Detailed Examination

    5.3 Key Market Opportunities

    5.3.1 New Drug Requirements for Faecal Microbiota

    5.3.2 Emerging Nations

    5.4 Future Trend

    5.4.1 The Human Microbiome - A New Frontier in Drug Discovery

    5.5 Impact analysis

    6. Human Microbiome Market – Global Analysis

    6.1 Global Human Microbiome Market Revenue Forecast and Analysis

    6.2 Global Human Microbiome Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Human Microbiome Market Analysis – By Product

    7.1 Overview

    7.2 Human Microbiome Market Revenue Share, by Product (2021 and 2028)

    7.3 Foods

    7.3.1 Overview

    7.3.2 Foods: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.4 Medical Food

    7.4.1 Overview

    7.4.2 Medical Food: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.5 Probiotics

    7.5.1 Overview

    7.5.2 Probiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.6 Prebiotics

    7.6.1 Overview

    7.6.2 Prebiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.7 Drugs

    7.7.1 Overview

    7.7.2 Drugs: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.8 Diagnostic Devices

    7.8.1 Overview

    7.8.2 Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    7.9 Supplements

    7.9.1 Overview

    7.9.2 Supplements: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8. Human Microbiome Market Analysis – By Disease

    8.1 Overview

    8.2 Human Microbiome Market Revenue Share, by Disease (2021 and 2028)

    8.3 Diabetes

    8.3.1 Overview

    8.3.2 Diabetes: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8.4 Cancer

    8.4.1 Overview

    8.4.2 Cancer: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8.5 Autoimmune Disorders

    8.5.1 Overview

    8.5.2 Autoimmune Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8.6 Obesity

    8.6.1 Overview

    8.6.2 Obesity: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8.7 Mental Disorders

    8.7.1 Overview

    8.7.2 Mental Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    8.8 Others

    8.8.1 Overview

    8.8.2 Others: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    9. Human Microbiome Market Analysis – By Application

    9.1 Overview

    9.2 Human Microbiome Market Revenue Share, by Application (2021 and 2028)

    9.3 Therapeutics

    9.3.1 Overview

    9.3.2 Therapeutics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    9.4 Diagnostics

    9.4.1 Overview

    9.4.2 Diagnostics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    10. Global Human Microbiome Market – Geographic Analysis

    10.1 North America: Human Microbiome Market

    10.1.1 Overview

    10.1.2 North America: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)

    10.1.3 North America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    10.1.4 North America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.1.5 North America Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    10.1.6 North America: Human Microbiome Market, by Country, 2021 & 2028 (%)

    10.1.6.1 US: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.1 US: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.2 US Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.3 US: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.1.6.1.4 US: Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2 Canada: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.1 Canada: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.2 Canada Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.3 Canada Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.1.6.2.4 Canada Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3 Mexico: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.1 Mexico: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.2 Mexico Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.3 Mexico Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.1.6.3.4 Mexico Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    10.2 Europe: Human Microbiome Market Revenue and Forecasts to 2028

    10.2.1 Overview

    10.2.2 Europe: Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.3 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.4 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.5 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6 Europe Human Microbiome Market Revenue and Forecasts to 2028, By Country (%)

    10.2.6.1 Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.1.1 Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.1.2 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.1.3 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.1.4 Germany Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6.2 UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.2.1 UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.2.2 UK Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.2.3 UK Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.2.4 UK Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6.3 France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.3.1 France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.3.2 France Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.3.3 France Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.3.4 France Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6.4 Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.4.1 Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.4.2 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.4.3 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.4.4 Italy Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6.5 Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.5.1 Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.5.2 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.5.3 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.5.4 Spain Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.2.6.6 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.6.1 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    10.2.6.6.2 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    10.2.6.6.3 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    10.2.6.6.4 Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    10.3 Asia Pacific: Human Microbiome Market

    10.3.1 Overview

    10.3.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2028 (USD Million)

    10.3.3 Asia Pacific: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.4 Asia Pacific: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.5 Asia Pacific: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.6 Asia Pacific: Human Microbiome Market, by Country, 2021 & 2028 (%)

    10.3.7 China: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.7.1 China: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.7.2 China: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.7.3 China: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.7.4 China: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.8 Japan: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.8.1 Japan: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.8.2 Japan: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.8.3 Japan: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.8.4 Japan: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.9 India: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.9.1 India: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.9.2 India: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.9.3 India: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.9.4 India: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.10 Australia: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.10.1 Australia: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.10.2 Australia: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.10.3 Australia: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.10.4 Australia: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.11 South Korea: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.11.1 South Korea: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.11.2 South Korea: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.11.3 South Korea: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.11.4 South Korea: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.3.12 Rest of Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.12.1 Rest of Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    10.3.12.2 Rest of Asia Pacific: Human Microbiome Market, By Product, 2019–2028 (USD Million)

    10.3.12.3 Rest of Asia Pacific: Human Microbiome Market, by Disease, 2019–2028 (USD Million)

    10.3.12.4 Rest of Asia Pacific: Human Microbiome Market, by Application, 2019–2028 (USD Million)

    10.4 Middle East and Africa: Human Microbiome Market

    10.4.1 Overview

    10.4.2 Middle East & Africa: Human Microbiome Market- Revenue and Forecast to 2028 (US$ Million)

    10.4.3 Middle East and Africa Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.4.4 Middle East and Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.4.5 Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.4.6 Middle East and Africa: Human Microbiome Market, by Country, 2021 & 2028 (%)

    10.4.6.1 Saudi Arabia: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.1.1 Saudi Arabia: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.1.2 Saudi Arabia Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.4.6.1.3 Saudi Arabia Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    10.4.6.1.4 Saudi Arabia Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.4.6.2 UAE: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.2.1 UAE: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.2.2 UAE Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.4.6.2.3 UAE Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    10.4.6.2.4 UAE Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.4.6.3 South Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.3.1 South Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.3.2 South Africa Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.4.6.3.3 South Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    10.4.6.3.4 South Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.4.6.4 Rest of Middle East and Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.4.1 Rest of Middle East and Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    10.4.6.4.2 Rest of Middle East and Africa Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.4.6.4.3 Rest of Middle East and Africa Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    10.4.6.4.4 Rest of Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.5 South and Central America: Human Microbiome Market

    10.5.1 Overview

    10.5.2 South and Central America: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.3 South and Central America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    10.5.4 South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.5.5 South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.5.6 South and Central America: Human Microbiome Market, by Country, 2021 & 2028 (%)

    10.5.6.1 Brazil: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.1 Brazil: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.2 Brazil Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.3 Brazil Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.5.6.1.4 Brazil Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.5.6.2 Argentina: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.1 Argentina: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.2 Argentina Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.3 Argentina Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    10.5.6.2.4 Argentina Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    10.5.6.3 Rest of South and Central America: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.1 Rest of South and Central America: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.2 Rest of South and Central America Human Microbiome Market, by Product– Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.3 Rest of South and Central America Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    10.5.6.3.4 Rest of South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    11. Impact Of COVID-19 Pandemic on Human Microbiome Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    12. Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market, (%)

    12.3 Organic Developments

    12.3.1 Overview

    12.4 Inorganic Developments

    12.4.1 Overview

    13. Company Profiles

    13.1 MaaT Pharma

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 ELIGO BIOSCIENCE

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 AOBiome

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 Kaleido Biosciences, Inc.

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 Seres Therapeutics

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Merck & Co., Inc.

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 Yakult Honsha Co., Ltd.

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 Rebiotix, Inc.

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 DuPont de Nemours, Inc.

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 Synthetic Biologics, Inc.

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms


    LIST OF TABLES

    Table 1. North America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 2. North America Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)

    Table 3. North America Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)

    Table 4. US Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 5. US Human Microbiome Market, by Disease - Revenue and Forecast to 2028 (USD Million)

    Table 6. US Human Microbiome Market, by Application - Revenue and Forecast to 2028 (USD Million)

    Table 7. Canada Human Microbiome Market, by Product -Revenue and Forecast to 2028 (USD Million)

    Table 8. Canada Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 9. Canada Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 10. Mexico Human Microbiome Market, by Product -Revenue and Forecast to 2028 (USD Million)

    Table 11. Mexico Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 12. Mexico Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 13. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn).

    Table 14. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).

    Table 15. Europe and Middle East and Africa Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).

    Table 16. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Product US$ Mn)

    Table 17. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).

    Table 18. Germany Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).

    Table 19. UK Human Microbiome Market Revenue and Forecasts to 2028, By Product US$ Mn)

    Table 20. UK Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn).

    Table 21. UK Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn).

    Table 22. France Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 23. France Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    Table 24. France Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 25. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 26. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    Table 27. Italy Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 28. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 29. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    Table 30. Spain Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 31. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Product (US$ Mn)

    Table 32. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Disease (US$ Mn)

    Table 33. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028, By Application (US$ Mn)

    Table 34. Asia Pacific: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)

    Table 35. Asia Pacific Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 36. Asia Pacific Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 37. China: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)

    Table 38. China: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 39. China: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 40. Japan: Human Microbiome Market, By Product– Revenue and Forecast to 2028 (USD Million)

    Table 41. Japan: Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    Table 42. Japan: Human Microbiome Market, by Application – Revenue and Forecast to 2028 (USD Million)

    Table 43. India: Human Microbiome Market, By Product– Revenue and Forecast to 2028 (USD Million)

    Table 44. India: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 45. India: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 46. Australia: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)

    Table 47. Australia: Human Microbiome Market, by Disease– Revenue and Forecast to 2028 (USD Million)

    Table 48. Australia: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 49. South Korea: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)

    Table 50. South Korea: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 51. South Korea: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 52. Rest of Asia Pacific: Human Microbiome Market, By Product – Revenue and Forecast to 2028 (USD Million)

    Table 53. Rest of Asia Pacific: Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 54. Rest of Asia Pacific: Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 55. Middle East and Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 56. Middle East and Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 57. Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 58. Saudi Arabia Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 59. Saudi Arabia Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 60. Saudi Arabia Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 61. UAE Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 62. UAE Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 63. UAE Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 64. South Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 65. South Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 66. South Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 67. Rest of Middle East and Africa Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 68. Rest of Middle East and Africa Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 69. Rest of Middle East and Africa Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 70. South and Central America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 71. South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 72. South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 73. Brazil Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 74. Brazil Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 75. Brazil Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 76. Argentina Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 77. Argentina Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 78. Argentina Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 79. Rest of South and Central America Human Microbiome Market, by Product – Revenue and Forecast to 2028 (USD Million)

    Table 80. Rest of South and Central America Human Microbiome Market, by Disease – Revenue and Forecast to 2028 (USD Million)

    Table 81. Rest of South and Central America Human Microbiome Market, by Application– Revenue and Forecast to 2028 (USD Million)

    Table 82. Organic Developments Done By Companies

    Table 83. Inorganic Developments Done by Companies

    Table 84. Glossary of Terms, Human Microbiome Market


    LIST OF FIGURES

    Figure 1. Human Microbiome Market Segmentation

    Figure 2. Human Microbiome Market Segmentation, By Region

    Figure 3. Global Human Microbiome Market Overview

    Figure 4. Probiotics Segment Held the Largest Share of the Product Segment in Human Microbiome Market

    Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

    Figure 6. Human Microbiome Market, by Geography (US$ Million)

    Figure 7. Global Human Microbiome Market – Leading Country Markets (US$ Million)

    Figure 8. Global Human Microbiome Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia pacific PEST Analysis

    Figure 12. Middle East and Africa PEST Analysis

    Figure 13. South and Central America PEST Analysis

    Figure 14. Human Microbiome Market Impact Analysis of Driver and Restraints

    Figure 15. Global Human Microbiome Market – Revenue Forecast and Analysis – 2020- 2028

    Figure 16. Global Human Microbiome Market – By Geography Forecast and Analysis – 2021- 2028

    Figure 17. Market Positioning of Key Players in Global Human Microbiome Market

    Figure 18. Human Microbiome Market Revenue Share, by Product (2021 and 2028)

    Figure 19. Foods: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 20. Medical Food: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Probiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22. Prebiotics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23. Drugs: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24. Diagnostic Devices: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Supplements: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26. Human Microbiome Market Revenue Share, by Disease (2021 and 2028)

    Figure 27. Diabetes: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 28. Cancer: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 29. Autoimmune Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 30. Obesity: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 31. Mental Disorders: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 32. Others: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 33. Human Microbiome Market Revenue Share, by Application (2021 and 2028)

    Figure 34. Therapeutics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 35. Diagnostics: Human Microbiome Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 36. North America: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)

    Figure 37. North America Human Microbiome Market Revenue and Forecast to 2028 (USD Million)

    Figure 38. North America: Human Microbiome Market, by Country, 2021 & 2028 (%)

    Figure 39. US: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 40. Canada: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 41. Mexico: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 42. Europe: Human Microbiome Market Revenue Overview, by Country, 2021 (US$ MN)

    Figure 43. Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 44. Europe Human Microbiome Market Revenue and Forecasts to 2028, By Country (%)

    Figure 45. Germany Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 46. UK Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 47. France Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 48. Italy Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 49. Spain Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 50. Rest of Europe Human Microbiome Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 51. Asia Pacific: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)

    Figure 52. Asia Pacific Human Microbiome Market Revenue and Forecast to 2028 (USD Million)

    Figure 53. Asia Pacific: Human Microbiome Market, by Country, 2021 & 2028 (%)

    Figure 54. China: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 55. Japan: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 56. India: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 57. Australia: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 58. South Korea: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 59. Rest of Asia Pacific: Human Microbiome Market – Revenue and Forecast to 2028 (USD Million)

    Figure 60. Middle East and Africa: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)

    Figure 61. Middle East & Africa Human Microbiome Market Revenue and Forecast to 2028 (US$ Million)

    Figure 62. Middle East and Africa: Human Microbiome Market, by Country, 2021 & 2028 (%)

    Figure 63. Saudi Arabia: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    Figure 64. UAE: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    Figure 65. South Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    Figure 66. Rest of Middle East and Africa: Human Microbiome Market– Revenue and Forecast to 2028 (US$ Million)

    Figure 67. South and Central America: Human Microbiome Market, by Key Country – Revenue (2021) (USD Million)

    Figure 68. South and Central America Human Microbiome Market Revenue and Forecast to 2028 (USD Million)

    Figure 69. South and Central America: Human Microbiome Market, by Country, 2021 & 2028 (%)

    Figure 70. Brazil: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    Figure 71. Argentina: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    Figure 72. Rest of South and Central America: Human Microbiome Market– Revenue and Forecast to 2028 (USD Million)

    Figure 73. Impact of COVID-19 Pandemic In North American Country Markets

    Figure 74. Impact of COVID-19 Pandemic In European Country Markets

    Figure 75. Impact of COVID-19 Pandemic In Asia Pacific Country Markets

    Figure 76. Impact Of COVID-19 Pandemic In Rest of the World Market

    Figure 77. Impact Of COVID-19 Pandemic in Rest of the World Market

    Figure 78. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Human Microbiome Market

    1. Rebiotix Inc.
    2. Yakult Honsha Co., Ltd.
    3. Synthetic Biologics Inc.
    4. DuPont
    5. MaaT Pharma
    6. Eligo Bioscience
    7. Merck & Co. Inc
    8. AOBiome LLC
    9. Kaleido
    10. Seres Therapeutics
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market. 
    • Highlights key business priorities in order to assist companies to realign their business strategies. 
    • The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies. 
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. 
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. 
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPBT00002233
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.
    The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.
    The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst